Lisa’s 7-Week Protocol Update — Tumour Shrinking, Fasting, and the Gut Connection

Lisa Drake shared an impressively structured and deeply honest update on her 7-week experimental protocol, reporting further tumour mass reduction but not yet full remission.

While initial tumour volume was measured at 2900mm³, recent scans provided only partial dimensions or vague terms like “stable” or “slightly reduced,” making accurate tracking difficult. Lisa now estimates the remaining tumour is between 0.8–1.2cm.

Her protocol blended repurposed drugs, targeted supplements, intense fasting, metabolic strategies, and emotional healing. Despite occasional lapses, Lisa’s progress, resilience, and self-awareness drew wide admiration from the community.

✅ Key Protocol Components Shared

Cycle structure:

2 weeks on: Full drug + supplement protocol
1 week off: Alternate days of dry fasting and keto
Repeat
Final off week: 4 days dry fast (no food/water/showering) + 3 days water-only fast

Morning:

Matcha + dandelion + soursop tea
Liquid Kurk (bioavailable curcumin – 20% Onconomics sensitivity)
Capecitabine (2x 500mg – 81%)
Frankincense Carterii (3x 500mg – 25%)
Genistein (3x 125mg – 25%)
Quercetin (3x 500mg – 30%)
Agaricus blazei (3x)
Sodium Phenylbutyrate (4x 500mg – glutamine antagonist)

Lunch (keto/carnivore):

Fenbendazole
Propranolol
Cimetidine
Loratadine
Dipyridamole
Metformin
Naltrexone
Celebrex
Sodium Phenylbutyrate

Dinner:

Repeat morning/afternoon stack
Capecitabine taken only when protein intake is high

✅ Scientific & Philosophical Insights

Imaging inconsistencies raised questions about how to accurately measure tumour change over time.
Use of the Onconomics test to personalize supplement selection shows the value of precision-guided therapy.
Acknowledged that 7 weeks may not have been enough — 12 weeks is a more realistic window for response.
Lisa is considering shifting from attack mode (blocking pathways) to a deeper focus on gut healing and system balance, reflecting a philosophical evolution in her healing journey.
Deep insights into how gut health, trauma history, and mental health can act as barriers to progress — especially with a 20-year history of bulimia and occasional lapses.

✅ Practical Wisdom from Community

Community support was high — many praised her discipline, transparency, and protocol structure.
Kidney impact of Celebrex (celecoxib) discussed — Lisa confirmed it did raise her markers after 6 months, but she reversed the change within 2 weeks by stopping the drug and using sauna.
Lisa noted she only takes Celebrex once daily, not twice as prescribed.
Emphasized tools that helped emotionally and physically:
Struggled with sleep, EMF overload from screens, and some dietary lapses (e.g., keto junk food, occasional alcohol) — but owned these with honesty and humor.

✅ Resources & References Shared

Onconomics test used to determine supplement sensitivity
Planning MetaExplore GI mapping + microbiome testing
Will test for pathogens, mold, and overlooked markers
Shared reflections on bulimia’s role in gut dysfunction and its relevance to digestive cancers
Added photos from Instagram to show visual context

✅ Key Takeaways

Tumour continues to shrink — no disease progression since diagnosis in May 2023
All pelvic lymph nodes remain clear — a major milestone
Despite facing financial strain and emotional challenges, Lisa stayed consistent with a powerful stack of therapies
Her journey is an inspiring reminder that progress isn’t always linear, and perfection isn’t required
The next phase focuses on gut healing, pathogen testing, and emotional recovery — a full-body, full-being approach to healing
Lisa’s honesty and detail offer both protocol insight and emotional courage to everyone in the community

Original Post

0 comments